Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes
- PMID: 15709166
Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes
Abstract
Objective: In patients with oral squamous cell carcinoma, a high proportion of T cells in the tumor undergo apoptosis, which correlates with Fas ligand (FasL) expression on tumor cells VSports手机版. The present study was done to identify mechanisms responsible for apoptosis of T cells seen in the peripheral circulation of these patients. .
Methods: Sera of 27 patients, normal donor sera, and supernatants of cultured normal or tumor cells were fractionated by size exclusion chromatography and ultracentrifugation to isolate microvesicles. The presence of microvesicle-associated FasL was studied by Western blots, blocking with anti-Fas reagents, and immunoelectron microscopy V体育安卓版. Biological activities of microvesicles were tested including the ability to induce apoptosis of Jurkat and T-cell blasts. Semiquantitative analysis of FasL in microvesicles was correlated with caspase-3 activity, DNA fragmentation, cytochrome c release, loss of mitochondrial membrane potential, and TCR-zeta chain expression in lymphocytes. .
Results: FasL-positive (FasL+) microvesicles were detected in sera of 21 of 27 patients. Microvesicles contained 42 kDa FasL. These microvesicles induced caspase-3 cleavage, cytochrome c release, loss of mitochondrial membrane potential, and reduced TCR-zeta chain expression in target lymphocytes. Biological activity of the FasL+ microvesicles was partially blocked by ZB4 anti-Fas monoclonal antibody V体育ios版. Microvesicle-associated FasL levels correlated with the patients' tumor burden and nodal involvement. .
Conclusion: Sera of patients with active oral squamous cell carcinoma contain FasL+ microvesicles, which induce the receptor and mitochondrial apoptotic pathways in Jurkat and activated T cells. VSports最新版本.
VSports注册入口 - Comment in
-
Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?Clin Cancer Res. 2005 Feb 1;11(3):968-70. Clin Cancer Res. 2005. PMID: 15709161 No abstract available.
Publication types
- VSports注册入口 - Actions
MeSH terms
- Actions (V体育官网)
- V体育官网入口 - Actions
- VSports注册入口 - Actions
- Actions (V体育安卓版)
- "VSports注册入口" Actions
- Actions (VSports注册入口)
- Actions (VSports注册入口)
- V体育ios版 - Actions
- "VSports" Actions
- "VSports app下载" Actions
- VSports - Actions
- "VSports手机版" Actions
- V体育官网 - Actions
- VSports app下载 - Actions
- V体育ios版 - Actions
- "VSports app下载" Actions
- Actions (VSports)
- "V体育2025版" Actions
- VSports在线直播 - Actions
- Actions (VSports注册入口)
Substances
- "VSports手机版" Actions
- Actions (V体育2025版)
- V体育官网入口 - Actions
- "VSports在线直播" Actions
- "VSports在线直播" Actions
Grants and funding (VSports注册入口)
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous